Emergent forges five-year partnership to produce one billion doses of Janssen’s COVID-19 vaccine
July 7, 2020Manufacturing and Production COVID-19, Emergent, J&J, JJ, Janssen, coronavirus
As many pharma firms move to secure upscaled manufacturing capacity for their potential COVID-19 vaccines, Johnson & Johnson’s Janssen has …
Johnson & Johnson cuts price of anti-TB medicine in poorer countries
July 7, 2020Manufacturing and Production J&J, JJ, TB
Johnson & Johnson have announced that it will cut the price of its tuberculosis drug Bedaquiline, sold under the brand …
Jonathan Sackler, co-owner of Purdue Pharma, dies from cancer
July 7, 2020Manufacturing and Production Purdue, opioid, opioid crisis
Jonathan Sackler, son of Purdue Pharma founder Raymond Sackler, died on 30 June from cancer, according to the company. He …
Tesla to offer “microfactories” to scale up production of CureVac’s potential COVID-19 vaccine
July 6, 2020Manufacturing and Production, Sales and Marketing COVID-19, CureVac, Vaccine, tesla
Electric car firm Tesla has announced it will be supplying mobile molecular printer capacity to German firm CureVac, and possibly …
ViiV Healthcare secures FDA approval for Rukobia combo in multidrug-resistant HIV-1
July 6, 2020Sales and Marketing FDA, HIV, ViiV Healthcare
ViiV Healthcare, the HIV specialist majority owned by GSK which also counts Shionogi and Pfizer among its shareholders, has secured …
US moving remdesivir supplies to COVID-19 hotspots
July 6, 2020Sales and Marketing Arizona, COVID, states, texas
The US government is sending significant remdesivir supplies to states that are being hit hardest by the coronavirus. Florida, Arizona …
Florida issues warning over ‘brain-eating’ amoeba
July 6, 2020Sales and Marketing amoeba, infection, lakes
The Florida Department of Health has issued a warning over a rare case of ‘brain-eating’ amoeba after one person has …
WHO halt coronavirus trials of hydroxychloroquine, lopinavir and ritonavir
July 6, 2020Sales and Marketing COVID, COVID-19, WHO, coronavirus
The World Health Organization has discontinued trials into the viability of hydroxychloroquine, lopinavir and ritonavir as COVID-19 treatments. This was …
Europe extends Invokana indication to cover diabetic kidney disease in type 2 diabetes patients
July 3, 2020Medical Communications, Research and Development Europe, Mundipharma, invokana
European Commission has moved to expand the existing approved indication for Mundipharma’s Invokana (canagliflozin), making it the first sodium glucose co-transporter …
US anti-racism protests did not cause spike in coronavirus cases, new study shows
July 3, 2020Medical Communications COVID-19, coronavirus
Widespread protests against racism and police brutality did not cause a significant spike in coronavirus cases in the US, according …
Promising early immunogenicity data for Pfizer and BioNTech’s COVID vaccine candidate
July 3, 2020Medical Communications, Research and Development BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech have revealed new efficacy findings on the “most advanced” of four candidates being worked on as part …
Texas mandates the wearing of facemasks in public
July 3, 2020Medical Communications COVID-19, coronavirus
Texas becomes the latest state in the US to mandate the wearing of facemasks in public, as COVID-19 cases skyrocket …
Top Ten most popular articles on Pharmafile.com this week
July 3, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronaviurs, top 10
Gilead features prominently in the news this week, as the US bought most of the world’s stock of the company’s …
EUSA Pharma gets FDA green light to evaluate IL-6 inhibitor siltuximab in COVID-19 patients
July 2, 2020Research and Development COVID-19, Eusa Pharma, siltuximab
Efforts push on to discover an effective treatment for COVID-19 in more than 100 different drug candidates worldwide. EUSA Pharma …
COVID-19 immunity may be more widespread than previously thought, new study suggests
July 2, 2020Business Services coronaviurs, covid-29, herd immunity
Coronavirus immunity in the world’s population may be more widespread than initially thought, even in those who have tested negative …
European Commission announces approval for Janssen’s Ebola vaccine
July 2, 2020Business Services EC, Ebola, Ebola Vaccines
Johnson & Johnson announced that the European Commission has granted Marketing Authorisation for its Janssen Ebola vaccine. Two Marketing Authorisation …
Drug industry suing to overturn Minnesota insulin affordability law
July 2, 2020Business Services diabetes, insulin, type 1, type 2
The drug industry is suing to overturn a Minnesota law that requires companies to provide emergency insulin to diabetics who …
UK Government accused of withholding Pillar 2 COVID-19 data which show Leicester had 10 times more cases than reported pre-lockdown
July 1, 2020Medical Communications, Research and Development, Sales and Marketing COVID-19, UK
The UK Government warned when relaxing lockdown measures on 23 June that it would not hesitate to lock down any …
FDA approves Pfizer and Merck KGaA’s Bavencio for maintenance of advanced bladder cancer
July 1, 2020Research and Development, Sales and Marketing Bavencio FDA, EMD Serono, Merck, Pfier
The FDA has moved to approve Bavencio (avelumab), developed by Pfizer and EMD Serono, the biopharma arm of Merck KGaA, …
Takeda partners up with Carmine Therapeutics to develop and market rare disease candidates
July 1, 2020Research and Development Takeda Carmine, partnership, pharma
Takeda has linked up with Carmine Therapeutics in a new partnership to discover, develop and bring to market new non-viral …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
